Key Highlights
● Third-quarter adjusted EPS of $0.58 compared with $0.50 a year earlier
● 2026 adjusted EPS guidance raised by $0.40 to more than $5.20
● Total Debt cut by $1.1 billion to $15.5 billion during the quarter
● Marketplace membership dropped from 5.83 million to 3.40 million
What moved Centene (NYSE:CNC) on Wednesday? Not much. Shares of the largest US Medicaid managed-care company closed at $70.45 on November 11, 2026, up $0.26 or about 0.4%. They traded between roughly $69.77 and $71.08. Volume of about 4.2 million shares was below the stock's average of roughly 6.6 million. The S&P 500 rose 1.3% on a tech-led rebound, so Centene lagged the benchmark on a quiet day for the stock.
No catalyst on the day, after a volatile week
There was no material company-specific news on Wednesday. Centene filed no Earnings update, guidance change or major SEC filing that day, and no new analyst rating change was reported. The only company item was a November 10 announcement that its Illinois subsidiary, Meridian Health Plan, would fund nearly $1.2 million of maternal-health work with March of Dimes. That is a community program, not a financial catalyst. Bernstein's Lance Wilkes kept a Buy rating and $79 price target on November 4, but that was a reiteration a week old.
The small gain makes more sense against the previous six sessions. On November 4, after Democrats were projected to win both chambers of Congress, Centene jumped 12.6% to $76.01. Hospital and insurer stocks rallied on the view that a Democratic Congress could delay parts of the 2025 Medicaid cuts and possibly restore enhanced ACA marketplace subsidies. Centene then gave back much of that gain, closing at $74.17 on November 5, $69.74 on November 6 and $68.54 on November 9, before rising 2.4% to $70.19 on November 10. Wednesday's small move looks like a stock settling after that post-election swing while investors wait for clearer policy details.
What Centene does
Centene is a government-sponsored health insurer. It manages Medicaid benefits for states, runs Medicare Advantage and Medicare prescription drug plans, and is the longest-running carrier on the ACA marketplace, all through locally branded health plans. At September 30 it had 25.7 million at-risk members, including about 10.5 million traditional Medicaid members, 3.4 million marketplace members and nearly 9 million Medicare PDP enrollees.
Why Revenue per employee is high
Centene ranks 74th among US companies with the highest revenue per employee, at about $3.19 million per employee on a fiscal-year basis. The reason is the managed-care model. Centene books the full premium paid by states, the federal government and individuals as revenue, even though most of it goes straight back out as payments to hospitals, doctors and pharmacies. The company's own staff handle administration, care management and claims, not the medical care itself. That pushes revenue per employee very high, but the benefit to profit is small. Centene's health benefits ratio was 92.7% in the third quarter, which means about 93 cents of every premium dollar went to medical costs.
Recent financials and valuation
Third-quarter results, released October 27, showed total revenue of $50.6 billion, up from $49.7 billion a year earlier. Adjusted diluted EPS was $0.58, compared with $0.50 in the prior-year quarter, and the GAAP result was a loss of $0.14 per share. Medicaid premium and service revenue rose 4% to $24.0 billion and Medicare rose 20% to $11.3 billion, while commercial revenue fell 21% as marketplace membership dropped from 5.83 million to 3.40 million. Management raised 2026 adjusted EPS guidance by $0.40 to more than $5.20 and narrowed the full-year health benefits ratio range to 90.4% to 91.1%. It also cut total debt by $1.1 billion during the quarter to $15.5 billion and redeemed its 2027 senior notes in October.
At $70.45, Centene trades at about 13.5 times the floor of its 2026 adjusted EPS guidance. The Market Value is roughly $35 billion and the trailing P/E about 24. The stock has risen sharply over the past year. Its 52-week range runs from $31.63 to $78.08, and the one-year return was about 110% as of early November.
Sector context
Managed-care stocks are being driven by Washington more than by quarterly earnings. The 2025 budget law, H.R. 1, cut federal Medicaid funding and introduced work requirements that begin January 1, 2027, though federal officials can give some states more time. Enhanced ACA subsidies expired at the end of 2025, which helps explain Centene's sharp drop in marketplace enrollment. The midterm result raised hopes that some of these changes could be softened, but no legislation has passed and any bill would still need the president's signature. Investors are also watching state Medicaid rates. Just over 40% of Centene's Medicaid revenue gets new rates on January 1, 2027, and management said there are signs those rates will better match costs.
Risks
The main risk is a gap between rates and medical costs. As work requirements remove some members from Medicaid rolls, the members who remain could cost more to cover than state rates assume. Centene's margins are thin. The trailing operating Margin is about 0.7%, so small cost misses can wipe out profits, as the 2025 losses and a $6.7 billion Goodwill write-down showed. Marketplace membership has nearly halved, and political hopes for restored subsidies may not be met. Operating Cash Flow was negative $3.7 billion in the third quarter, which management attributed to payment timing. Provider billing disputes also required a larger reserve in the quarter.
Policy Signals and 2027 Rates
Over the next few weeks, the main issues are signals from Congress on Medicaid and ACA Subsidy legislation, the final 2027 state Medicaid rate notices and early 2027 marketplace enrollment data. Management has said it expects earnings growth in 2027, with formal 2027 guidance due alongside fourth-quarter results in February. Until then, the stock is likely to move more on policy news than on company announcements.






Please wait processing your request...